These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3335928

  • 1. Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cells.
    Piwnica-Worms D, Kronauge JF, Holman BL, Lister-James J, Davison A, Jones AG.
    J Nucl Med; 1988 Jan; 29(1):55-61. PubMed ID: 3335928
    [Abstract] [Full Text] [Related]

  • 2. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells.
    Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG.
    J Nucl Med; 1990 Apr; 31(4):464-72. PubMed ID: 2324822
    [Abstract] [Full Text] [Related]

  • 3. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.
    Piwnica-Worms D, Kronauge JF, Chiu ML.
    Circulation; 1990 Nov; 82(5):1826-38. PubMed ID: 2225379
    [Abstract] [Full Text] [Related]

  • 4. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells.
    Piwnica-Worms D, Kronauge JF, Chiu ML.
    J Nucl Med; 1991 Oct; 32(10):1992-9. PubMed ID: 1919744
    [Abstract] [Full Text] [Related]

  • 5. The utilization of technetium-99m CPI as a myocardial perfusion imaging agent in exercise studies.
    Sia ST, Holman BL, Campbell S, Lister-James J, English RJ, Kronauge JF, Davison A, Jones AG.
    Clin Nucl Med; 1987 Sep; 12(9):681-7. PubMed ID: 3665310
    [Abstract] [Full Text] [Related]

  • 6. Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.
    Maublant JC, Gachon P, Moins N.
    J Nucl Med; 1988 Jan; 29(1):48-54. PubMed ID: 3335927
    [Abstract] [Full Text] [Related]

  • 7. Myocardial imaging with technetium-99m CPI: initial experience in the human.
    Holman BL, Sporn V, Jones AG, Sia ST, Perez-Balino N, Davison A, Lister-James J, Kronauge JF, Mitta AE, Camin LL.
    J Nucl Med; 1987 Jan; 28(1):13-8. PubMed ID: 3794805
    [Abstract] [Full Text] [Related]

  • 8. Uptake of hexakis(t-butylisonitrile) technetium (I) and hexakis(isopropylisonitrile) technetium (I) by neonatal rat myocytes and human erythrocytes.
    Sands H, Delano ML, Gallagher BM.
    J Nucl Med; 1986 Mar; 27(3):404-8. PubMed ID: 3754888
    [Abstract] [Full Text] [Related]

  • 9. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts.
    Chiu ML, Kronauge JF, Piwnica-Worms D.
    J Nucl Med; 1990 Oct; 31(10):1646-53. PubMed ID: 2213187
    [Abstract] [Full Text] [Related]

  • 10. Comparative myocardial uptake characteristics of hexakis (alkylisonitrile) technetium(I) complexes. Effect of lipophilicity.
    Piwnica-Worms D, Kronauge JF, Holman BL, Davison A, Jones AG.
    Invest Radiol; 1989 Jan; 24(1):25-9. PubMed ID: 2917819
    [Abstract] [Full Text] [Related]

  • 11. Cationic complexes of technetium for myocardial imaging.
    Gerundini P, Maffioli L.
    J Nucl Med; 1989 Aug; 30(8):1415-9. PubMed ID: 2666598
    [Abstract] [Full Text] [Related]

  • 12. A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.
    Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ.
    J Nucl Med; 1984 Dec; 25(12):1350-5. PubMed ID: 6334145
    [Abstract] [Full Text] [Related]

  • 13. Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells.
    Maublant JC, Moins N, Gachon P.
    Eur J Nucl Med; 1989 Dec; 15(4):180-2. PubMed ID: 2753050
    [Abstract] [Full Text] [Related]

  • 14. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells.
    Kronauge JF, Chiu ML, Cone JS, Davison A, Holman BL, Jones AG, Piwnica-Worms D.
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):141-8. PubMed ID: 1601667
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of the 99mTc-CPI myocardial perfusion imaging.
    Liu XJ, Wang XB, Liu YZ, He ZX, Guo XZ, Shi RF, Wang YQ, Lu P, Zhang WH, Wu QW.
    Eur J Nucl Med; 1989 Feb; 15(6):277-9. PubMed ID: 2788576
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of Tc-99m hexakis t-butyl isonitrile in normal and ischemic canine myocardium.
    Williams SJ, Dragotakos DL, Okada RD.
    Eur J Nucl Med; 1989 Feb; 15(6):287-91. PubMed ID: 2767078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of the 99mTc-labeled myocardial imaging agent, hexakis (t-butylisonitrile)-technetium.
    Liu XJ, Shi RF, Wang YQ, Guo XZ, He ZX, Wang XB, Liu BL.
    Eur J Nucl Med; 1987 Feb; 13(4):171-3. PubMed ID: 3622563
    [Abstract] [Full Text] [Related]

  • 19. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.
    Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG.
    Cancer Res; 1990 Apr 01; 50(7):2198-202. PubMed ID: 2317808
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.